Shawn Tomasello, Chief Commercial Officer at Kite Pharma, Inc. (KITE), sold 8,406 shares at $179.66 ($1.5M) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $1.5M KITE by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.66 | 4,203 | $755K | 50.0% |
| 2 | $179.66 | 4,203 | $755K | 50.0% |
| Total | $179.66 avg | 8,406 | $1.5M | 100% |
| Filing → |
| DPLO | SELL | 2019-10-04 | $4K | — | Filing → |
| DPLO | SELL | 2019-06-05 | $6K | — | Filing → |
| DPLO | SELL | 2018-06-05 | $41K | — | Filing → |